Delivery Order W81K0225DA021-W81K0225FA154
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $1.9M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a delivery order to Roche Diagnostics Corporation on October 1, 2025, for Roche Ventana Medical System platforms, including reagents and instruments, with a ceiling value of $354,964.92. The order is a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by September 30, 2026. The work will be performed in Castleton, Indiana. This delivery order represents a child contract under a larger vehicle, enabling the Defense...
- The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...
- The Defense Health Agency (DHA) awarded a delivery order to Roche Diagnostics Corporation for the provision of Roche test reagents in Fiscal Year 2025. This delivery order, designated as Option III, covers the period from October 1, 2024, through September 30, 2025, with a ceiling value of $295,532.69 under a firm fixed-price contract type. The award was made on October 1, 2024, with performance taking place in Castleton, Indiana. No set-aside designation was applied to this contract award. This...
- The Defense Health Agency awarded a $31,230 delivery order to Roche Diagnostics Corporation for customized reagents and consumables on September 2, 2025. This firm fixed price contract, which serves as a child order under a larger contract vehicle, will be performed in Castleton, Indiana. The award carries no set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned manufacturer specializing in in vitro diagnostics and...
- The Defense Health Agency awarded a delivery order to Roche Diagnostics Corporation on December 1, 2022, for the provision of clinical chemistry and immunoassay analyzers on a cost-per-test basis. This firm fixed-price contract, valued at approximately $3.62 million with a completion date of September 30, 2027, will be performed in Castleton, Indiana. The contract was issued without set-aside designation, allowing Roche Diagnostics to compete openly in the federal marketplace. This delivery...
- This is a $1,831,969.56 delivery order awarded by the Defense Health Agency to Roche Diagnostics Corporation for the Fiscal Year 2025 delivery of a Roche total laboratory automation line and 3 Cobas 8000 chemistry analyzers to support the Madigan Army Medical Center. The delivery order is a firm fixed-price contract and does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, and has provided similar...
- Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a firm fixed price delivery order against an existing contract vehicle to provide laboratory detection kits to the Defense Health Agency. The $385,588.62 contract has no set-aside designation and requires completion by December 6, 2023. Roche will supply the kits from its location in San Diego, California in support of the Defense Health Agency's medical laboratory capabilities at military treatment...
- The Defense Health Agency awarded a $354,964.81 firm-fixed-price delivery order to Roche Diagnostics Corporation to provide test reagents for Fiscal Year 2023 from October 1, 2022 to September 30, 2023. The order was placed against one of Roche Diagnostics' existing Indefinite Delivery Contracts or Blanket Purchase Agreements with the federal government. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $750,000 firm fixed price delivery order under the Critical Analyzers, Laboratory (FSS-66-III) master GSA Schedule. The order is for Roche System Processing Supplies to be provided from Roche's place of performance in Castleton, Indiana, covering the period from July 1, 2022 through December 31, 2022. Roche Diagnostics Corporation will supply laboratory testing supplies and consumables to support the DOD's medical laboratory...